Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?-Reference-Cited by-同舟云学术

Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?

Published:2024-03-01 Issue:5 Volume:31 Page:3186-3193
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Costarelli Leopoldo,Arienzo Francesca,Broglia Laura,La Pinta Massimo,Scavina Paola,Meli Emanuele Zarba,Colavito Maria Helena,Ascarelli Alessandra,Campagna Domenico,Mastropietro Tiziana,Manna Elena,Amato Michela,Andrulli Angela Damiana,Schiavone Alfonso,Minelli Mauro,Fortunato Lucio

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-15052-y.pdf

Reference59 articles.

1. He PS, Li F, Li GH, Guo C, Chen TJ. The combination of blue dye and radioisotope versus radioisotope alone during sentinel lymph node biopsy for breast cancer: a systematic review. BMC Cancer. 2016;16:107.

2. Shirzadi A, Mahmoodzadeh H, Qorbani M. Assessment of sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer in two subgroups: initially node-negative and node-positive converted to node-negative: a systemic review and meta-analysis. J Res Med Sci. 2019;24:18.

3. Park S, Park JM, Cho JM, Park HS, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytological proven node-positive breast cancer diagnosis. Ann Surg Oncol. 2013;20:2858–65.

4. Hiecken TJ, Boughey JC, Jones KN, Shah SS, et al. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Ann Surg Oncol. 2013;20:3199–204.

5. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455–61.